Cargando…

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

AIM OF THE STUDY: Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Juuti, Anne, Nordling, Stig, Fermér, Christian, Nilsson, Olle, Seppänen, Hanna, Haglund, Caj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459962/ https://www.ncbi.nlm.nih.gov/pubmed/26053486 http://dx.doi.org/10.1371/journal.pone.0129012

Ejemplares similares

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2016)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
por: Heby, Margareta, et al.
Publicado: (2020)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2021)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

A comparative study of two PODXL antibodies in 840 colorectal cancer patients
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer
por: Lanki, Mira, et al.
Publicado: (2019)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
por: Mattila, Nora, et al.
Publicado: (2018)

The possible dual role of Ang-2 in the prognosis of pancreatic cancer
por: Roos-Mattila, Matilda, et al.
Publicado: (2023)

Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma
por: Nurmi, Anna M., et al.
Publicado: (2021)

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Salmiheimo, Aino, et al.
Publicado: (2016)

Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma
por: Korpela, Taija, et al.
Publicado: (2022)

REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2019)

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2020)

N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
por: Nieminen, Heini, et al.
Publicado: (2023)

aMMP-8 POCT for Periodontal Disease: An Indicator of Poor Oral Health
por: Gupta, Shipra, et al.
Publicado: (2023)

Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017)

Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2022)

Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
por: Arpalahti, Leena, et al.
Publicado: (2018)

MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocol
por: Johansson, Katarina, et al.
Publicado: (2021)

Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
por: Vehviläinen, Sini, et al.
Publicado: (2021)

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer
por: Koskensalo, Selja, et al.
Publicado: (2012)

Pancreatic cancer survival prediction via inflammatory serum markers
por: Lanki, Mira, et al.
Publicado: (2022)

Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer
por: Gunnarsson, Ulf, et al.
Publicado: (2020)

The Prognostic Importance of CD20(+) B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
por: Edin, Sofia, et al.
Publicado: (2019)

MMP‐7, ‐8, ‐9, E‐cadherin, and beta‐catenin expression in 34 ameloblastoma cases
por: Kelppe, Jetta, et al.
Publicado: (2020)

N-glycomic Profiling as a Tool to Separate Rectal Adenomas from Carcinomas
por: Kaprio, Tuomas, et al.
Publicado: (2015)

Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
por: Kaprio, Tuomas, et al.
Publicado: (2021)

Association of periodontitis and complications after pancreatic surgery
por: Hermunen, Kethe M, et al.
Publicado: (2023)

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring
por: Mäkinen, Lotta, et al.
Publicado: (2022)

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status
por: Sjöblom, Anni, et al.
Publicado: (2021)

Polyomavirus JCPyV infrequently detectable in adenoid cystic carcinoma of the oral cavity and the airways
por: Hämetoja, Hanna, et al.
Publicado: (2019)

Stage I–IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1(+) Vessel Density
por: Ålgars, Annika, et al.
Publicado: (2021)

Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer
por: Koskensalo, Selja, et al.
Publicado: (2013)

High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2023)

IgG4-positive plasma cells in nonspecific sialadenitis and sialolithiasis
por: Peuraharju, Elin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5e07tiqobdftg7b9r157df7fa